Login / Signup

Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis.

Pietro AmeriVincenzo De MarzoGiuseppe Biondi ZoccaiLucia TricaricoMichele CorrealeNatale Daniele BrunettiMarco CanepaGaetano Maria De FerrariDavide CastagnoItalo Porto
Published in: European heart journal. Cardiovascular pharmacotherapy (2022)
Expanding pharmacotherapy beyond NEUi improves outcomes in HFrEF with CKD.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • healthcare
  • smoking cessation
  • metabolic syndrome
  • skeletal muscle
  • glycemic control
  • weight loss